New drug to protect babies and toddlers from RSV gets U.S. FDA approval ahead of cold season
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV
Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV
Use of the antibody treatment, the brand name for which is Beyfortus, still needs to be recommended by the ACIP.
Breaking News, Sports, Manitoba, Canada
WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of t
This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old in the United States every year.